Home
Events
Programas
Programa General
Programa de Conferencias
Memorias
CCI 2021
Memorias CCI 2023
Master conferences
Relatoría IV CCI UCLV 2023
0
Sign in
English (US)
English (US)
Español
All Events
Conference
7th International Chemistry Symposium
SIQ 2019
Introduction
Papers
Submit a paper
Agenda
Community
molecular docking
×
radiolabelling
×
Book your talks
Plan your experience by adding your favorites talks to your wishlist
Coming soon
Multicomponent preparation, characterization and in silico analysis of potential inhibitors of Pseudomonas aeruginosa quorum sensing receptor LasR
molecular docking
multicomponent reactions
pseudomonas aeruginosa
quorum sensing
MOLECULAR DOCKING STUDY ON THE INTERACTION BETWEEN 2-SUBSTITUTED-4,5-DIFURYL IMIDAZOLES WITH DIFFERENT PROTEIN TARGET FOR ANTILEISHMANIAL ACTIVITY.
2-substituted-4
5-difuryl imidazoles
antileishmanial activity
leishmania
molecular docking
IN VITRO EVALUATION OF ARYLSUBSTITUTED IMIDAZOLES AS ANTIPROTOZOAL AGENTS AND DOCKING STUDIES ON STEROL 14α-DEMETHYLASE (CYP51) FROM T. CRUZI, L. INFANTUM AND T. BRUCEI.
arylsusbtituted imidazoles
in vitro evaluation
leishmania infantum
molecular docking
trypanosoma b. rhodesiense
trypanosoma brucei
trypanosoma cruzi
MOLECULAR DOCKING STUDY ON THE INTERACTION BETWEEN 2-SUBSTITUTED-4,5-DIFURYL IMIDAZOLES WITH DIFFERENT PROTEIN TARGET FOR ANTILEISHMANIAL ACTIVITY.
2-substituted-4
5-difuryl imidazoles
antileishmanial activity
leishmania
molecular docking
MOLECULAR DOCKING STUDIES OF ARYLSUBSTITUTED IMIDAZOLES AND THE ONCOGENIC PROTEIN BCR-ABL TYROSINE KINASE.
aryl-substituted imidazoles
chronic myeloid leukemia (cml)
molecular docking
protein bcr-abl
Virtual screening and synthesis of novel tetrazole-thiadiazine-2-thionas hybrids
molecular docking
multicomponent reaction
tetrazole
thiadiazine
trypanosoma cruzi
trypanothione reductase
IDENTIFYING THE INTERACTIONS OF THREE IMMUNOSUPPRESSANTS WITH FKBP12 INTRAMOLECULAR RECEPTOR: A THEORETICAL STUDY
dual descriptor
fkbp12
molecular docking
radiolabelling
rapalogues
MOLECULAR DOCKING STUDIES OF ARYLSUBSTITUTED IMIDAZOLES AND THE ONCOGENIC PROTEIN BCR-ABL TYROSINE KINASE.
aryl-substituted imidazoles
chronic myeloid leukemia (cml)
molecular docking
protein bcr-abl
Gold
Gold
Gold
Gold
Gold
Gold